27.10.2011
Belarus, Kazakhstan to set up biopharmaceutical company
MINSK, 27 October (BelTA) – Belarus and Kazakhstan will establish a joint venture producing biopharmaceuticals, Director General of the National Center for Biotechnology of Kazakhstan Yerlan Ramankulov told reporters on 27 October, BelTA has learnt.
“We are considering a possibility to create infrastructure of a multi-purpose bacterial production to make a wide range of products for agriculture,” the expert said. The project is estimated at about $7 million. The production will be located in Kazakhstan. Kazakhstan is going to use Belarus’ expertise and knowledge. The project is expected to run 1-1.5 years. Taking part in it will be the Institute of Genetics and Cytology of the National Academy of Sciences of Belarus (NASB) and the Institute of Microbiology of the NASB. “We might also produce medicines,” Yerlan Ramankulov added.
Analyzing cooperation prospects of the two countries, the expert noted that the most promising cooperation avenues include microbiology for medicine, agriculture, and food industry. “We are interested in Belarusian technologies to produce bio-pesticides and preparations to enhance the yield and disease resistance of crops,” he said. Kazakhstan is also interested in Belarus’ legal framework in the field. “Belarus has advanced in regulating bio-security issues, we are greatly interested in the country’s expertise,” the Director General concluded.
Minsk is playing host to the conference “Innovative biotechnologies in the EurAsEC”. Taking part in it are scientists from Belarus, Russia, Kazakhstan, Tajikistan and Kyrgyzstan. They will discuss the implementation of the interstate target program of the EurAsEC (innovative biotechnologies) for 2011-2015. It is aimed to develop and introduce new biotechnologies, biopharmaceuticals and diagnostic test-systems for agriculture, industry, medicine and environmental protection.
“We are considering a possibility to create infrastructure of a multi-purpose bacterial production to make a wide range of products for agriculture,” the expert said. The project is estimated at about $7 million. The production will be located in Kazakhstan. Kazakhstan is going to use Belarus’ expertise and knowledge. The project is expected to run 1-1.5 years. Taking part in it will be the Institute of Genetics and Cytology of the National Academy of Sciences of Belarus (NASB) and the Institute of Microbiology of the NASB. “We might also produce medicines,” Yerlan Ramankulov added.
Analyzing cooperation prospects of the two countries, the expert noted that the most promising cooperation avenues include microbiology for medicine, agriculture, and food industry. “We are interested in Belarusian technologies to produce bio-pesticides and preparations to enhance the yield and disease resistance of crops,” he said. Kazakhstan is also interested in Belarus’ legal framework in the field. “Belarus has advanced in regulating bio-security issues, we are greatly interested in the country’s expertise,” the Director General concluded.
Minsk is playing host to the conference “Innovative biotechnologies in the EurAsEC”. Taking part in it are scientists from Belarus, Russia, Kazakhstan, Tajikistan and Kyrgyzstan. They will discuss the implementation of the interstate target program of the EurAsEC (innovative biotechnologies) for 2011-2015. It is aimed to develop and introduce new biotechnologies, biopharmaceuticals and diagnostic test-systems for agriculture, industry, medicine and environmental protection.